title: At AAN, biotechs tout their wares for MS.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Dalzell
mesh_terms: D001709:Biotechnology; D003226:Congresses as Topic; D017277:Drug Approval; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D014481:United States